WIM
BMY.RT

Westside Investment Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Westside Investment Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,047
Closed -$9 – 764
2020
Q4 		$9 Sell
13,047
-175
-1% -$373 ﹤0.01% 513
2020
Q3 		$29 Hold
13,222
– – ﹤0.01% 385
2020
Q2 		$47 Sell
13,222
-170
-1% -$613 ﹤0.01% 332
2020
Q1 		$50 Buy
+13,392
New +$44.1K ﹤0.01% 328

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Westside Investment Management's BMY.RT Position: Q1 2021 in Review

Westside Investment Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 13,047 shares — an estimated $9 sold.

Westside Investment Management first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $50 in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Westside Investment Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Westside Investment Management sold 13,047 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9.
  • Westside Investment Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Westside Investment Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $50 in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Westside Investment Management's 13F filing for Q1 2021, filed 14 Apr 2021.